- Home
- PMX vs SMTI Comparison
PMX vs SMTI Comparison
Compare PMX & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMX
- SMTI
- Stock Information
- Founded
- PMX 2002
- SMTI 1982
- Country
- PMX United States
- SMTI United States
- Employees
- PMX N/A
- SMTI N/A
- Industry
- PMX Trusts Except Educational Religious and Charitable
- SMTI Medical/Dental Instruments
- Sector
- PMX Finance
- SMTI Health Care
- Exchange
- PMX Nasdaq
- SMTI Nasdaq
- Market Cap
- PMX 233.7M
- SMTI 273.6M
- IPO Year
- PMX N/A
- SMTI N/A
- Fundamental
- Price
- PMX $6.83
- SMTI $28.88
- Analyst Decision
- PMX
- SMTI Strong Buy
- Analyst Count
- PMX 0
- SMTI 2
- Target Price
- PMX N/A
- SMTI $49.50
- AVG Volume (30 Days)
- PMX 101.5K
- SMTI 35.1K
- Earning Date
- PMX 01-01-0001
- SMTI 05-14-2025
- Dividend Yield
- PMX 5.28%
- SMTI N/A
- EPS Growth
- PMX N/A
- SMTI N/A
- EPS
- PMX N/A
- SMTI N/A
- Revenue
- PMX N/A
- SMTI $91,569,883.00
- Revenue This Year
- PMX N/A
- SMTI $23.53
- Revenue Next Year
- PMX N/A
- SMTI $5.93
- P/E Ratio
- PMX N/A
- SMTI N/A
- Revenue Growth
- PMX N/A
- SMTI 34.65
- 52 Week Low
- PMX $6.09
- SMTI $25.86
- 52 Week High
- PMX $8.47
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- PMX 48.28
- SMTI 39.00
- Support Level
- PMX $6.68
- SMTI $28.50
- Resistance Level
- PMX $6.89
- SMTI $29.82
- Average True Range (ATR)
- PMX 0.07
- SMTI 0.95
- MACD
- PMX -0.00
- SMTI -0.24
- Stochastic Oscillator
- PMX 58.00
- SMTI 21.02
About PMX PIMCO Municipal Income Fund III of Beneficial Interest
PIMCO Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as transportation, healthcare, and others.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.